Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure
Read time: 1 mins
Last updated:25th Sep 2013
The objective of this study is to conduct a population pharmacokinetic analysis of caspofungin in a population of patients with moderate and severe acute alcoholic hepatitis or liver disease with Child-Pugh score B and C in order to better characterize pharmacokinetic parameters in case of moderate and severe liver dysfunction.
|Study start date||2013-09-25|